Q3 2026 Sai Life Sciences Ltd Earnings Call Transcript
Key Points
- Sai Life Sciences Ltd (NSE:SAILIFE) reported a strong financial performance with a 27% year-on-year increase in total revenues for Q3 FY26, reaching INR556 crores.
- The company achieved a significant EBITDA growth of 54% year-on-year, translating to an EBITDA margin of 34%.
- The CDMO business contributed approximately 65% of the revenues, with a year-on-year growth of around 31%.
- Sai Life Sciences Ltd (NSE:SAILIFE) added seven molecules to its late phase and commercial pipeline, enhancing its business resilience.
- The company is on track with its capital expenditure program, with several expansions scheduled for completion in the near future, including R&D and manufacturing capacity increases.
- There is a concern about potential destocking in the future, which could impact revenue, although the company currently has no specific visibility of such events.
- The company faces challenges in maintaining its 28% to 30% EBITDA margin due to growth-related challenges and upfront investments in people and technology.
- Sai Life Sciences Ltd (NSE:SAILIFE) has a high concentration of revenue from a few products, with the top product accounting for around 12% of total revenue.
- The company is investing in new technologies and capabilities, which may not yield immediate returns and could impact short-term profitability.
- There is uncertainty in the oligonucleotide space, with low volumes and high complexity, which may not lead to significant revenue growth in the short term.
Ladies and gentlemen, good day and welcome to Sy Life Sciences Limited Q3 FY26 earnings call. (Operator Instructions) I now hand the conference over to Mr. Diwakar Pingley. Thank you and over to you.
Thank you. Good evening to all the participants on this call. Before we finish the call, let me remind you that the discussion may contain forward-looking statements that may involve known unknown risks, uncertainties, and other factors.
It must be viewed in conjunction with our that would cost futurism performance or achievements to differ significantly from what the best implied forward. Please note that we have made the results on the same. It's also available on the company's website.
In case you have not received the same, please write to us and we're happy to send the same over to you. To take us through the results and answer your question today, we have the top management of Senses Limited represented by Krishna Kanumuri, Managing Directorship of the Behaviour Officer.
And she was so full-time
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
